Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment

Medical Oncology

Volumn 16, Issue 4, 1999, Pages 245-254

  Knudsen, L M ^a   Rasmussen, T ^a   Jensen, L ^a   Johnsen, H E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Melphalan treatment; Multiple myeloma; Stem cells

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CELL COUNT; CELL PROLIFERATION; CELL STIMULATION; CLONOGENESIS; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0033387849     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02785870     Document Type: Article

References (27)